Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Piminxiao (also known as Piminxiao Capsules or Piminxiao Jiaonang) is a traditional Chinese medicine (TCM) formulation composed of 21 herbal ingredients, including Sophora flavescens, Atractylodes Rhizome, Saposhnikovia divaricata, Schizonepeta tenuifolia, Tribulus terrestris, Dictamnus dasycarpus, Cnidium monnieri, Xanthium sibiricum, Scolopendra subspinipes, Indigo Naturalis, Taraxacum mongolicum, Viola yedoensis, Scutellaria baicalensis, Phellodendron amurense, Coptis chinensis, Cryptotympana pustulata, Rehmannia glutinosa, Paeonia suffruticosa, Tamarix chinensis, Lithospermum erythrorhizon, and Lycium chinense. It is formulated to dispel wind, eliminate dampness, clear heat, detoxify, cool blood, and relieve itching. Piminxiao is primarily indicated for the treatment of allergic skin diseases, such as acute and chronic urticaria, acute eczema, atopic dermatitis, psoriasis, pityriasis rosea, and pruritus. It is developed and manufactured by Yifan Pharmaceutical and its subsidiaries, including Sichuan Defeng Pharmaceutical and Suzhou Yifan Pharmaceutical, and has been approved for marketing in China and Singapore.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Piminxiao.